Pyoderma gangrenosum and tumour necrosis factor alpha inhibitors: a semi‐systematic review
H Ben Abdallah, K Fogh, R Bech - International Wound Journal, 2019 - Wiley Online Library
Pyoderma gangrenosum (PG) is a rare ulcerative skin disease that presents a therapeutic
challenge. Tumour necrosis factor alpha (TNFα) inhibitors have been reported to …
challenge. Tumour necrosis factor alpha (TNFα) inhibitors have been reported to …
Biologic and small-molecule medications in the management of pyoderma gangrenosum
F McKenzie, D Cash, A Gupta… - Journal of …, 2019 - Taylor & Francis
Pyoderma gangrenosum (PG) is an uncommon inflammatory skin disorder characterized by
neutrophil dysfunction. There are currently no FDA-approved drugs for the treatment of this …
neutrophil dysfunction. There are currently no FDA-approved drugs for the treatment of this …
Cytokines as therapeutic targets in primary Sjögren syndrome
S Retamozo, A Flores-Chavez… - Pharmacology & …, 2018 - Elsevier
Primary Sjögren syndrome (SjS) is a systemic autoimmune disease that may affect 1 in 1000
people (overwhelmingly women) and that can be a serious disease with excess mortality …
people (overwhelmingly women) and that can be a serious disease with excess mortality …
The Pathophysiology and Treatment of Pyoderma Gangrenosum—Current Options and New Perspectives
M Łyko, A Ryguła, M Kowalski, J Karska… - International Journal of …, 2024 - mdpi.com
Pyoderma gangrenosum (PG) is an uncommon inflammatory dermatological disorder
characterized by painful ulcers that quickly spread peripherally. The pathophysiology of PG …
characterized by painful ulcers that quickly spread peripherally. The pathophysiology of PG …
Biologics in Sjögren's syndrome
C Skarlis, N Marketos, CP Mavragani - Pharmacological Research, 2019 - Elsevier
The use of biologic disease modifying antirheumatic drugs (bDMARDs) in systemic
autoimmune diseases such as rheumatoid arthritis and at a lesser extent in lupus, has been …
autoimmune diseases such as rheumatoid arthritis and at a lesser extent in lupus, has been …
Novel therapeutic approaches and targets for the treatment of neutrophilic dermatoses, management of patients with neutrophilic dermatoses and future directions in …
E Molinelli, V Brisigotti, M Paolinelli… - Current …, 2021 - ingentaconnect.com
Neutrophilic dermatoses are a heterogeneous group of inflammatory skin disorders
characterized by the presence of a sterile, predominantly neutrophilic infiltrate on …
characterized by the presence of a sterile, predominantly neutrophilic infiltrate on …
[PDF][PDF] Ulcerative Type Pyoderma Gangrenosum in Primary Sjogren's Syndrome
B GÜNDOĞDU, D ÇİÇEK… - … Klinikleri Journal of …, 2018 - pdfs.semanticscholar.org
Sjogren's syndrome (SjS) is a systemic chronic autoimmune disorder characterized by
lymphocytic infiltrates in exocrine organs. Most patients present with the dryness of mouth …
lymphocytic infiltrates in exocrine organs. Most patients present with the dryness of mouth …
Biologics in Wound Management
A De Pascalis, V Dini - Technology in Practical Dermatology: Non-Invasive …, 2020 - Springer
Biologics are a new class of drugs which mimic the action of human proteins and interact
with circulating proteins or cellular/extracellular targets, blocking their activities. The main …
with circulating proteins or cellular/extracellular targets, blocking their activities. The main …
Autoimmune Connective Tissue Diseases
JS Lehman, AG Bridges - Hospital-Based Dermatopathology: An Illustrated …, 2020 - Springer
Autoimmune connective tissue diseases (CTD) include a variety of chronic autoimmune
disorders that may affect one or multiple organ systems, with the skin being frequently …
disorders that may affect one or multiple organ systems, with the skin being frequently …
[引用][C] Two case reports of tofacitinib topical treatment: A game‐changer in the management of vasculitis ulcer?
V Haridas, C Hoskatti, SM Choukimath… - International Journal …, 2024 - Wiley Online Library
Dear Editor, Vasculitis is a group of rare diseases that cause inflammation of small, medium,
and large blood vessels. It can be primary (idiopathic) or secondary to autoimmune …
and large blood vessels. It can be primary (idiopathic) or secondary to autoimmune …